Article Text

Download PDFPDF
Are the loading dose treatment groups superior to the 150 mg without loading dose group in the secukinumab FUTURE 5 study?
  1. Bernardo Matos da Cunha
  1. Internal Medicine, Rheumatology Team, Sarah Network of Rehabilitation Hospitals, Brasília, DF, Brazil
  1. Correspondence to Dr Bernardo Matos da Cunha, Sarah Network of Rehabilitation Hospitals, Brasília-DF.; bmcunha{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

I read with great interest the article by Mease et al 1 because equivalence in efficacy with lesser secukinumab total doses could be less expensive to payers and more safe and comfortable to patients. However, I am somewhat disappointed with the reported results.

The …

View Full Text


  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; internally peer reviewed.